Profil
Rob Slack is currently Chief Scientific Officer at Vicore Pharma Holding AB since 2026.
Formerly, Dr. Slack was Vice President & Head-Respiratory Biology at GSK Plc and Chief Scientific Officer at Damora Therapeutics, Inc. Dr. Slack earned a doctorate from the University of Strathclyde.
Postes actifs de Rob Slack
| Sociétés | Poste | Début |
|---|---|---|
| VICORE PHARMA HOLDING AB | Directeur Technique/Scientifique/R&D | 06/07/2026 |
Anciens postes connus de Rob Slack
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Rob Slack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
















